The effects of oral and intramuscular administration and dose escalation of enrofloxacin on the selection of quinolone resistance among Salmonella and coliforms in pigs

Research in Veterinary Science

Volumn 75, Issue 3, 2003, Pages 185-193

  Wiuff, C ^a,b   Lykkesfeldt, J ^b   Svendsen, O ^b   Aarestrup, F M ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Enrofloxacin; Pigs; Resistance; Treatment regimes

Indexed keywords

CIPROFLOXACIN; ENROFLOXACIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERIUM MUTANT; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG FECES LEVEL; DRUG RESPONSE; ESCHERICHIA COLI; FECES ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE FLORA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SALMONELLA TYPHIMURIUM; SWINE DISEASE; WILD TYPE;

ESCHERICHIA COLI; SALMONELLA; SALMONELLA TYPHIMURIUM;

EID: 0141557971     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0034-5288(03)00112-7     Document Type: Article

References (19)

1. Angulo, F.J., Johnson, K.R., Tauxe, R.V., Cohen, M.L., 2000. Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: implications for the use of fluoroquinolones in food animals. Microbial Drug Resistance 6, 77-83.
2. Bager, F., Helmuth, R., 2001. Epidemiology of resistance to quinolones in Salmonella. Veterinary Research 32, 285-290.
3. Barrow, P.A., Lovell, M.A., Szmolleny, G., Murphy, C.K., 1998. Effect of enrofloxacin administration on excretion of Salmonella enteritidis by experimentally infected chickens and on quinolone resistance of their Escherichia coli flora. Avian Pathology 27, 586-590.
4. Brown, S.A., 1996. Fluoroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics 19, 1-14.
5. Davies, R.H., Teale, C.J., Wray, C., MC Laren, I.M., Jones, Y.E., Chappell, S., Kidd, S., 1999. Nalidixic acid resistance in salmonellae isolated from turkeys and other livestock in Great Britain. Veterinary Record 144, 320-322.
6. Edlund, C., Lindqvist, L., Nord, C.E., 1988. Norfloxacin binds to human fecal material. Antimicrobial Agents and Chemotherapy 32, 1869-1874.
7. Endtz, H.P.H., Ruijs, G.J., Klingeren, B., Jansen, W.H., Reyden, T., Mouton, P., 1991. Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. Journal of Antimicrobial Chemotherapy 27, 199-208.
8. Engberg, J., Aarestrup, F.M., Taylor, D.E., Gerner-Smidt, P., Nachamkin, I., 2001. Quinolone and macrolide resistance in Campylobacter jejuni and C coli: resistance mechanisms and trends in human isolates. Emergence of Infectious Diseases 7, 24-34.
9. Heurtin-Le Corre, C., Donnio, P.-Y., Perrin, M., Travert, M.-F., Avril, J.-L., 1999. Increasing incidence and comparison of nalidixic acid-resistant Salmonella enterica subsp. Enterica sertype Salmonella typhimurium isolates from humans and animals. Antimicrobial Agents and Chemotherapy 37, 266-269.
10. Hinton, M., Linton, A.H., 1985. The influence of flumequine on the resistance of the coliform flora of chickens to the agent. Journal of Veterinary Pharmacology and Therapeutics 8, 393-397.
11. Lewin, C.S., Morrissey, I., Smith, J.T., 1992. The bactericidal activity of sparfloxacin. Journal of Antimicrobial Chemotherapy 30, 625-632.
12. Malorny, B., Schroeter, A., Helmuth, R., 1999. Incidence of quinolone resistance over the period 1986 to 1998 in veterinary Salmonella isolates from Germany. Antimicrobial Agents and Chemotherapy 43, 2278-2282.
13. Medders, W.M., Wooley, R.E., Gibbs, P.S., Shotts, E.B., Brown, J., 1998. Mutation rate of avian intestinal coliform bacteria when pressured with fluoroquinolones. Avian Diseases 42, 146-153.
14. NCCLS, 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, fifth ed. Approved standard. M7-A5, NCCLS, Wayne, PA.
15. Nielsen, P., Gyrd-Hansen, N., 1997. Bioavailability of enrofloxacin after oral administration to fed and fasted pigs. Pharmacology and Toxicology 80, 246-250.
16. Piddock, L.J., 2002. Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals. Fems Microbiology Reviews 26, 3-16.
17. Wiuff, C., Madsen, M., Baggesen, D.L., Aarestrup, F.M., 2000. Quinolone resistance among Salmonella enterica from cattle, broilers, and swine in Denmark. Microbial Drug Resistance 6, 11-17.
18. Wiuff, C., Lykkesfeldt, J., Aarestrup, F.M., Svendsen, O., 2002. Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations. Journal of Veterinary Pharmacology and Therapeutics 25, 1-8.
19. Yabe, K., Murakami, Y., Nishida, S., Sekiguchi, M., Furuhama, K., Goryo, M., Okada, K., 2001. A non-arthropathic dose and its disposition following repeated oral administration of ofloxacin, a new quinolone antimicrobial agent, to juvenile dogs. Journal of Veterinary Medical Science 63, 867-872.